White paper
Breaking down barriers in cardiology trials to expand access to at-risk populations
Learn how to improve patient representation in cardiology trials through inclusive design, real-world data, and patient-centric strategies.
Discover how to break down barriers in cardiology trials to expand access to at-risk populations and ensure study populations more accurately mirror those most affected by cardiovascular disease. Representation in cardiology trials continues to lag behind clinical reality, with limited participation due to diagnostic gaps, socioeconomic pressures, cultural barriers and eligibility thresholds that do not reflect real-world health profiles.
Learn how to strengthen representation by:
- Addressing barriers limiting representation in cardiovascular research
- Building trust through culturally informed engagement
- Designing flexible trial pathways for an uneven digital world
- How real-world data are reshaping cardiology trial design
Key insights highlight the need for culturally aligned communication, hybrid digital and home-based services, thoughtful protocol design informed by real-world patient profiles and diversity planning as an integral part of protocol development, feasibility assessments and site engagement.
Trialmed brings more than four decades of operational and therapeutic experience, a global network of wholly owned and partnered sites and predictive data capabilities to engage patients, empower them and then enroll them.
Explore strategies for strengthening representation and improving the patient experience in your next cardiology study — download the white paper.